Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 2,006 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Discrete Clear all

Conditions: Unilateral Carpal Tunnel Syndrome
Interventions: StimRouter System; Device
Lead sponsor: Bioness Inc; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Breast Cancer
Interventions: Focus Group; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 21 Years to 99 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cancer-related Fatigue, Neuromodulation
Interventions: Active tDCS + elbow flexion exercise, Sham tDCS + elbow flexion exercise; Device · Drug
Lead sponsor: Kessler Foundation; Other
Eligibility: 40 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation
Interventions: MitraClip TMVR and Watchman LAAO; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Epilepsy
Interventions: Temporal Interference Electrical Stimulation; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Clear Cell Renal Carcinoma
Interventions: MK-3475, Bevacizumab; Drug
Lead sponsor: Arkadiusz Z. Dudek, MD; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 9
States / cities: Chicago, Illinois • Iowa City, Iowa • Ann Arbor, Michigan + 5 more

Conditions: Anterior Knee Pain Syndrome, Patellofemoral Pain Syndrome
Interventions: Dry Needling, Soft Tissue Mobilization, Placebo Control, Hip and core strengthening exercises; Other
Lead sponsor: Mitchell Selhorst; Other
Eligibility: 13 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Risk-Taking, Adolescent Behavior
Interventions: Pathways for African-Americans' Success (PAAS); Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 11 Years to 14 Years
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Irvine, California

Conditions: Ankle Fractures
Interventions: Fibular intramedullary nail, Open reduction and internal fixation; Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 85 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cherry Angioma
Interventions: Electrodessication, Pulsed dye laser (PDL), potassium titanyl phosphate (KTP); Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 95 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Exercise
Interventions: Graded-Intensity Treadmill Exercise Protocol; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Olfactory Dysfunction, Smell Loss, Anosmia, Hyposmia
Interventions: Sudoku Puzzles, ScentCare (Olfactory Training Device); Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Down Syndrome, Intellectual Disability, Sexuality, Parent-Child Relations
Interventions: Parent training; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: Not listed
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Park Ridge, Illinois

Conditions: Barrett Esophagus, Esophageal Adenocarcinoma
Interventions: Sample Collection, Endoscopy results, Dietary questionnaire; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: New York, New York

Conditions: Arthritis, Rheumatoid
Interventions: BI 695500, Rituxan®, MabThera®; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 54
States / cities: Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 48 more

Conditions: Interstitial Cystitis
Interventions: Onabotulinumtoxin A, injections upper aspect of trigone of urinary bladder, injections on posterior bladder wall excluding the trigone; Drug · Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy
Interventions: P7435, Placebo; Drug · Other
Lead sponsor: Piramal Enterprises Limited; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: See One, Do One, Order One
Interventions: See One, Do One, Order One; Behavioral
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 1,211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: All
Interventions: Re-Engineered Hospital Discharge; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 749 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: Brown University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Arterial Stiffness
Interventions: Fish Oil; Dietary Supplement
Lead sponsor: Salisbury University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Salisbury, Maryland

Conditions: Breast Cancer With Low to Intermediate HER2 Expression
Interventions: Echocardiogram; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Venous Distension Reflex, Blood Pressure
Interventions: Wrist-to-elbow (W-E) occlusion, ketorolac tromethamine, saline control; Other · Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 21 Years to 35 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Postoperative Pain
Interventions: Bolus, Basal; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: La Jolla, California

Search by objective public record fields.

Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves

Patient-centered Communication About Healthy Weight in Early Breast Cancer

tDCS for Cancer-Related Fatigue and Weakness

Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)

Cognitive and Electrophysiological Assessment of Non-Invasive Temporally-Interfering Electric Fields Stimulation (TIEFS)

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Manual Therapy to Treat Gluteus Medius Trigger Points

Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects

Diabetic Fibular Nail Study

Comparison of Electrodessication, Potassium Titanyl Phosphate (KTP) Laser and Pulsed Dye Laser for Treatment of Cherry Angiomata

Pro-rEsolving and pRo-inflammatory reSPonses to Acute exhaustIve exeRcisE in Healthy Individuals

Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome

The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)

Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis

Intravesicular Onabotulinumtoxin A in Interstitial Cystitis

Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units

Testing the Re-Engineered Hospital Discharge

Criticality, Working Memory, and Effort

Minimum Time Effect of Fish Oil on Arterial Stiffness

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

Autonomic Control of the Circulation and VDR

Continuous TAP Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus Doses